DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fosrenol (Lanthanum Carbonate) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Fosrenol (Lanthanum Carbonate) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Fosrenol side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female

Reactions: Large Intestine Perforation, Constipation, Peritonitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Fosrenol
    Dosage: 4.5 g, 1x/day:qd (4500 mg daily dose)
    Administration route: Oral
    Indication: Renal Failure Chronic
    Start date: 2011-11-01
    End date: 2012-01-08

Fosrenol
    Dosage: 1 g, 3x/day:tid (3000 mg daily)
    Administration route: Oral
    Indication: Hyperphosphataemia
    Start date: 2011-09-01
    End date: 2011-12-01

Other drugs received by patient: Oxycodone HCL; Caltrate / 00944201 /



Possible Fosrenol side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-18

Patient: female

Reactions: Large Intestine Perforation, Constipation, Peritonitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Fosrenol
    Dosage: 4.5 g, 1x/day:qd (4500 mg daily dose)
    Administration route: Oral
    Indication: Renal Failure Chronic
    Start date: 2011-12-01
    End date: 2012-01-08

Fosrenol
    Dosage: 1 g, 3x/day:tid (3000 mg daily)
    Administration route: Oral
    Indication: Hyperphosphataemia
    Start date: 2011-09-01
    End date: 2011-12-01

Other drugs received by patient: Oxycodone HCL; Caltrate / 00944201 /



Possible Fosrenol side effects in female

Reported by a physician from United States on 2012-07-16

Patient: female

Reactions: Large Intestine Perforation, Constipation, Peritonitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Fosrenol
    Dosage: 1 g, 3x/day:tid (3000 mg daily)
    Administration route: Oral
    Indication: Hyperphosphataemia
    Start date: 2011-09-01
    End date: 2011-12-01

Fosrenol
    Dosage: 4.5 g, 1x/day:qd (4500 mg daily dose)
    Administration route: Oral
    Indication: Renal Failure Chronic
    Start date: 2011-12-01
    End date: 2012-01-08

Other drugs received by patient: Caltrate / 00944201 /; Oxycodone HCL



Possible Fosrenol side effects in 69 year old female

Reported by a consumer/non-health professional from Canada on 2012-05-15

Patient: 69 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Abdominal Pain, Confusional State, Personality Change, Drug Level Increased, Intestinal Obstruction, Delirium, Faecaloma

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Fosrenol
    Indication: Blood Phosphorus Abnormal

Fosrenol
    Dosage: 500 mg, 3x/day:tid
    Administration route: Oral
    Indication: Hyperphosphataemia
    Start date: 2011-10-01
    End date: 2012-01-01

Other drugs received by patient: Glipizide; Iron; Insulin; Simvastatin; Colace; Laxatives; Alfacalcidol; Gabapentin; Metoprolol Tartrate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012